Skip to main content
See every side of every news story
Published loading...Updated

Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery

LAGUNA HILLS, Calif. and SHANGHAI, Aug. 10, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a…

30 Articles

The Union DemocratThe Union Democrat
+25 Reposted by 25 other sources
Center

Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery

LAGUNA HILLS, Calif. and SHANGHAI, Aug. 10, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a…

Closing a 100 million Series B in 2026 requires more than a brilliant algorithm: it requires a closed circuit that generates its own experimental data. Aureka Biotechnologies just proved it. The round: 100 million for a biological foundational model The company, founded in 2023, announced on August 10 the closing of a 100 million dollar Series B. The first stretch has covered it in exclusive Granite Asia, and a strategic investor has led a secon…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 91% of the sources are Center
91% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

technext24.com broke the news on Monday, August 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal